Medicinal Products and Pharma Funded Homecare [5749446]

CPV: Home medical treatment services · Homedelivery of provisions · Pharmaceutical products

Places

up to 25 suppliers · 31 bids on the busiest of 2 lots (1.2 per place) · 31 appointed (full)

Every one of these 2 lots carries the same published figure, £597,750,000: it is the framework's maximum for the whole notice, not each lot's own budget, and no share per lot is published. The cards below say ceiling above rather than repeat it.

Procedure method

Open procedure

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Goods

Notice status

Awarded

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Framework agreement

Who may use this agreement

Not stated in the notice; call-off rights may be limited to the establishing authority

Competition type

Competitive procedure

GPA / WTO covered

Yes (GPA)

Recurring procurement

Yes

First published

23 Jul 2024, 14:32 BST

Last source update

17 Jun 2025, 13:20 BST

Award evaluation window

24 Feb 2025 – …

FTS notice number

2025/S 000-032941

Classification (CPV)

Home medical treatment servicesHomedelivery of provisionsPharmaceutical products

Delivery area

Northern Ireland (UKN)

Official registry OCID

ocds-h6vhtk-0483bc Find a Tender

Publisher note: The value stated in II.1.7 and V.2.4 are based on current usage multiplied by the highest cost tendered price for each product line for which bids were received for. However, it is expected that additional products may be added during the term of the framework which may result in an increase in spend under the framework. Furthermore, the framework value may be impacted by potential price variances during the framework term. As such, the maximum value attributed to this framework will be 1,195,500,000 GBP (i.e. the advertised estimated total value as per notice 2024/S 000-035856) to ensure there is sufficient scope for additional products, call-off contracts and price variations over the term of the framework.. . In Section I.2 it is stated that this procurement is a joint procedure. This contract is not a joint contract, it is a central purchasing body contract operated by the Business Services Organisation, Procurement and Logistics Service on behalf of the participants listed in I.1.

Appointment period ends

24 Feb 2025, 15:00 GMT

Submission channel

{"written"}

Accepted languages

en

Bids opened

24 Feb 2025, 15:30 GMT

2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

• ABBVIE LTDFramework contractor ABBVIE HOUSE, MAIDENHEAD, UK, SL6 4UBContact email, phoneShow contact details
• AMAROX LIMITEDFramework contractor Congress House 14 Lyon Road, HARROW, UK, HA1 2ENContact email, phoneShow contact details
• AMGEN LTDFramework contractor 240 Cambridge Science Park, Milton Road, CAMBRIDGE, UK, CB4 0WDContact email, phoneShow contact details
• ASPIRE PHARMA LIMITEDFramework contractor BELLAMY HOUSE, PETERSFIELD, UK, GU31 4ADContact email, phoneShow contact details
• ASTRAZENECA PHARMACEUTICALS LIMITEDFramework contractor 600 Capability Green, LUTON, UK, LU1 3LUContact email, phoneShow contact details
• AVENTIS PHARMA LTDFramework contractor 410 Thames Valley Park Drive, READING, UK, RG6 1PTContact email, phoneShow contact details
• Accord-UK LTDFramework contractor WHIDDON VALLEY, BARNSTAPLE, UK, EX32 8NSContact email, phoneShow contact details
• BIOGEN IDEC LIMITEDFramework contractor Biogen | B5, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD | United Kingdom, Bristol, UK, SL6 3UDContact email, phoneShow contact details
• CELLTRION HEALTHCARE UNITED KINGDOM LIMITEDFramework contractor The Charter Builiding, Uxbridge, UK, UB8 1JGContact email, phoneShow contact details
• CHIESI LTDFramework contractor Highfield, CHEADLE, UK, SK8 3GYContact email, phoneShow contact details